Bim induction is required for targeted therapy-induced apoptosis of colon, lung, and breast cancers; for example, siRNA-mediated Bim downregulation impaired apoptosis of Her2+ BT474 cells in response to Lapatinib treatment [26, 28, 33, 34]. Here, BCL2L11 is linked to breast cancer.